FDA: Deliveries Of Scarce Childhood Cancer Drug Due To Resume, But Not Until Late October

FDA says deliveries of the vital childhood cancer drug vincristine, currently in very short supply across the U. S. should resume in late October.

Read the full post on Forbes - Healthcare

Victoria Forster, Contributor